Honeywell’s quantum technology venture Quantinuum has filed an initial public offering (IPO) registration statement with the U.S. Securities and Exchange Commission (SEC), making the filing publicly available. The move is described by multiple outlets as a step in Quantinuum’s process toward listing on U.S. public markets. The SEC filing is an “S-1” document, which typically initiates regulatory review and signals that a company is preparing for potential share issuance, though it does not guarantee the IPO will proceed. The announcements also frame the filing as part of Quantinuum’s broader effort to raise capital and accelerate its commercial and research activities in quantum computing. All reporting emphasizes that the latest development is the public release and formal submission of the IPO documentation, marking progress in the lead-up to possible trading, while details such as pricing and the final timing of the offering would depend on subsequent SEC review and market conditions.
Honeywell’s Quantinuum files for U.S. IPO, moving toward public markets
Honeywell’s quantum technology venture Quantinuum has filed an initial public offering (IPO) registration statement with the U.S. Securities and Exchange Commission (SEC), making the filing publicly a...
2 sources
3 months ago
5 views
Key Points
- Quantinuum, Honeywell’s quantum venture, files an S-1 IPO registration statement with the U.S. SEC.
- The IPO filing becomes publicly available, reflecting progress toward a possible listing.
- Reporting characterizes the filing as a procedural step that starts SEC review.
- The S-1 filing does not by itself confirm the IPO will proceed or finalize terms like timing and pricing.
How Outlets Covered This Story
SEE
CHA
CHA
Channel NewsAsia (CNA)
Honeywell's Quantinuum moves closer to public markets with US IPO filing
3 months ago
Related Stories
EquipmentShare.com faces securities class action over alleged investor losses
EquipmentShare.com Inc. (NASDAQ: EQPT) is named in multiple securities class action lawsuits alleging violations of U.S....
2 sources
1 month ago
Capricor Therapeutics Faces Securities Class Action; Lead Plaintiff Deadline Set for Sept. 28, 2026
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is facing a securities class action alleging violations of federal securities...
2 sources
3 weeks ago
Dodgers keep Shohei Ohtani off the mound due to lingering left knee soreness
The Los Angeles Dodgers remove Shohei Ohtani from pitching as he manages a lingering left knee issue. Multiple reports s...
9 sources
1 month ago